Controlled Release of Gentamicin Sulfate from Poly(3-hydroxybu-tyrate-co-3-hydroxyvalerate) Wafers for the Treatment of Osteomyelitis

  • Gilson Khang (Department of Polymer Science and Technology, Chonbuk National University) ;
  • Park, Hak-Soo (Department of Polymer Science and Technology, Chonbuk National University) ;
  • John M. Rhee (Department of Polymer Science and Technology, Chonbuk National University) ;
  • Yoon, Sung-Chul (Biomaterials Science Laboratory, Division of Life Science, Gyeongsang National University) ;
  • Cho, Jin-Cheol (Biomaterials Laboratory, Korea Research Institutes of Chemical Technology) ;
  • Lee, Hai-Bang (Biomaterials Laboratory, Korea Research Institutes of Chemical Technology)
  • Published : 2000.12.01

Abstract

Biodegradable wafers were prepared with poly (hydroxybutyrate-co-hydroxyvalerate) (PHBV;5, 10, and 15 mole% for 3-hydroxyvalerate) by simple heat pressing method for the sustained release of antibiotic agent, gentamicin sulfate (GS) to investigate the possibility of the treatment for osteomyelitis. The effects of hydroxyvalerate (HV) content, thickness of wafers, various types of additives such as sodium dodecyl sulfate (SDS), microcrystalline cellulose, polyvinylpyrrolidone, and hydroxypropylcellulose (HPC), and different initial drug loading ratio on the release profile have been investigated. In vitro release studies showed that different release patterns and rates could be achieved by simply modifying factors in the preparation conditions. PHBV wafers with 3 mm thickness, 10% of GS initial loading, 15% of HV content and addition of 5% of SDS and HPC were free from initial burst and a near-zero-order sustained release was observed for over 30 days. It might be suggested that the mechanisms of G5 release may be more predominant simple dissolution and diffusion of GS than erosion of PHBV in our system.

Keywords

References

  1. T.G.van Rens and F.H. KEyser,(Eds.) Septopal a Mew way of Local Antibiotic Teraphy, in Local Antibiotic Treatment in Osteomy-elitis and Soft Tissue Infections K.Klemm
  2. J. Control.Rel. v.23 no.209 J.Mauduit;N.Buhk;M.vert
  3. J.Bone Joint Surgery v.60-B no.270 H.Wahlig;E.Dingeldein;R.Bergmann;K.Reuss
  4. Drug Dev. Ind.Pharm v.15 no.2339 D.H.Robinson;S.S.Sambath
  5. J.Bone Joint Surgery v.68-A no.1297 S.B.Trippel
  6. J.Control.Rel. v.2 no.179 Y.Ikada;S.H.Hyon;K.Jamshidi;S.Higashi;T.Yamamuro
  7. J.Biomed.Mater.Res. v.26 no.1053 K.Yamamura;H.Iwata;T.Yotsuyanagi
  8. J.Pharm. v.78 no.165 S.S.Sampath;K.Garvin;D.H.Robinson
  9. Korea Polymer J. v.7 no.79 J.C.Cho;G.Khang;J.M.Rhee;Y.S.Kim;J.S.Lee;H.B.Lee
  10. Polym. Mater.Eng. v.53 no.620 J.A.Patterson;T.R.Tice;W.E.Meyers;J.W.Vin-cent;G.C.Battisone
  11. J.Bone Joint Surgery v.74-B no.600 Y.Shinto;A.Uchida;E.Korkusuz;M.Araki;K.Ono
  12. J. Pharm. Sci. v.65 no.1563 D.Yu;J.Wong;Y.Matsuda;J.L.Fox;W.I.Higu-chi;M.ostuda
  13. Drug Dev.Ind.Pharm. v.13 no.1651 A.A.Firsov;A.D.NararovlI.P.Fomia
  14. J.Macromol.Sci.-Macromol.Chem. v.A30 no.933 X.Zhang;p.Wyss;D.Pichora;M.F.A.Goosen
  15. J.Bone Joint Sur-gery v.73-B no.246 G.Wei;Y.Katoura;M.Oka;T.yamamauro;R.Wada;S.H.Hyon;Y.Ikada
  16. J. Bone Joint Sur-gery v.73-B no.246 S. Gogolewski;M.Jovanoic;S.M.Perren;J.G.Dillon;M.K.Hughes
  17. J.M.S.-Rev. Macromol. Chem. Phys. v.C82 no.35 P.J.Hocking
  18. J.Microencapsula-tion v.8 no.185 N. Gangrade;J.C.Price
  19. Drug News Perspec-tives v.2 no.89 S. Akhtar;C.W.Pouton
  20. CRC Crit.Rev.Therp.Drug Carrier Syst. v.3 no.209 K.Juni;M.Nakano
  21. J. Microencapsula-tion v.13 no.709 T. W. Atkin;S.J.Peacock
  22. J.Microencapsulation v.12 no.185 I.Gursel;V.Hasirci
  23. J., Con-trol.Rel. v.49 no.1 B.R.Conway;J.E.Eyles;H.O.Alpar
  24. J.Control.Rel v.9 no.149 F. Koosa;R.H.Muller;S.S.Davis;M.C.Davies
  25. J. Control. Rel. v.4 no.25 K. Juni;m.Nakano;M.Kubota
  26. Bio-Med. Mater. Eng. G. Khang;S.W. Kim;J.C.Cho;J.M.Rhee;S.C.Yoon
  27. J. Pharm. Pharmacol. v.40 no.118 S.Akhtar;C.W.Pouton;L.J.Notarianni;P.L.Gould
  28. Bio-Med. Mater. Eng. v.9 no.49 G. khang;J.C.Cho;J.W.Lee;J.M.Rhee;H.B.Lee
  29. Polymer Preprints v.40 no.288 G. khang;J.C.Cho;J.M.Rhee;J.S.Lee;H.B.Lee
  30. Korea Polymer J. v.8 no.80 G. khang;J.H.Lee;;J.W.Lee;J.C.Cho;H.B.Lee
  31. CRC Crit. Rev. Therap. Drug Carrier Syst. v.12 no.1 H. Okada;H.Toguchi